Novel Small Molecules in IBD: Current State and Future Perspectives

by André Jefremow, Markus F. Neurath
Published 2023-06-01

CRISPR/Cas9 in Gastrointestinal Malignancies

by André Jefremow, Markus F. Neurath, Maximilian J. Waldner
Published 2021-11-01

Real-World Data for Lenvatinib in Hepatocellular Carcinoma (ELEVATOR): A retrospective multicenter study

by Sabrina Welland, Catherine Leyh, Fabian Finkelmeier, André Jefremow, Kateryna Shmanko, Maria A. Gonzalez-Carmona, Arne Kandulski, Petia Jeliazkova, Jan Best, Thorben W. Fründt, Angela Djanani, Maria Pangerl, Andreas Maieron, Richard Greil, Christina Fricke, Disorn Sookthai, Rainer Günther, Andreas Schmiderer, Henning Wege, Marino Venerito, Ursula Ehmer, Martina Müller, Christian P. Strassburg, Arndt Weinmann, Jürgen Siebler, Oliver Waidmann, Christian M. Lange, Anna Saborowski, Arndt Vogel
Published 2022-01-01

REal life study of LEnVAtiNib therapy for HepAtocellular carcinoma: RELEVANT study

by Andrea Casadei-Gardini, Margherita Rimini, Masatoshi Kudo, Shigeo Shimose, Toshifumi Tada, Goki Suda, Myung Ji Goh, Andre Jefremow, Mario Scartozzi, Giuseppe Cabibbo, Claudia Campani, Emiliano Tamburini, Francesco Tovoli, Kazuomi Ueshima, Tomoko Aoki, Hideki Iwamoto, Takuji Torimura, Takashi Kumada, Atsushi Hiraoka, Masanori Atsukawa, Ei Itobayashi, Hidenori Toyoda, Naoya Sakamoto, Takuya Sho, Wonseok Kang, Jürgen Siebler, Markus Friedrich Neurath, Valentina Burgio, Stefano Cascinu
Published 2022-07-01